BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT Trademark

Trademark Overview

On Wednesday, May 9, 2018, a trademark application was filed for BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT with the United States Patent and Trademark Office. The USPTO has given the BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT trademark a serial number of 87913691. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by BiiG THERAPEUTICS LIMITED. The BRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT trademark is filed in the Pharmaceutical Products and Treatment & Processing of Materials Services categories with the following description:

Manufacture of pharmaceuticals and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases to order and/or specification of others

Pharmaceutical and biopharmaceutical drugs and medicines for treatment of acute and chronic infectious diseases
brii biosciences breakthrough innovation & insight

General Information

Serial Number87913691
Word MarkBRII BIOSCIENCES BREAKTHROUGH INNOVATION & INSIGHT
Filing DateWednesday, May 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Goods and ServicesManufacture of pharmaceuticals and biopharmaceutical drugs and medicines for the treatment of acute and chronic infectious diseases to order and/or specification of others
Description of MarkThe mark consists of a capitalized letter "B", followed by a lower case "r", followed by geometric shapes organized to represent two lower case letter "i's" as well as human figures, followed by the word "Biosciences". The words "Breakthrough Innovation & Insight" are centered directly below the words "Brii Biosciences".
Goods and ServicesPharmaceutical and biopharmaceutical drugs and medicines for treatment of acute and chronic infectious diseases
Pseudo MarkBREAKTHROUGH INNOVATION AND INSIGHT BIOSCIENCES BREAKTHROUGH INNOVATION AND INSIGHT
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOSCIENCES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, May 17, 2018
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBRII BIOSCIENCES LIMITED
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSHANGHAI 201203
CN
Party NameBRII BIOSCIENCES LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressSHANGHAI 201203
CN
Party NameBiiG THERAPEUTICS LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSHANGHAI 201203
CN

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 1, 2021SOU EXTENSION 5 GRANTED
Wednesday, September 22, 2021SOU EXTENSION 5 FILED
Wednesday, September 22, 2021SOU TEAS EXTENSION RECEIVED
Monday, June 14, 2021ASSIGNED TO EXAMINER
Saturday, April 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 15, 2021SOU EXTENSION 4 GRANTED
Thursday, April 15, 2021SOU EXTENSION 4 FILED
Thursday, April 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, September 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 21, 2020SOU EXTENSION 3 GRANTED
Monday, September 21, 2020SOU EXTENSION 3 FILED
Monday, September 21, 2020SOU TEAS EXTENSION RECEIVED
Friday, April 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 15, 2020SOU EXTENSION 2 GRANTED
Wednesday, April 15, 2020SOU EXTENSION 2 FILED
Wednesday, April 15, 2020SOU TEAS EXTENSION RECEIVED
Thursday, October 31, 2019DIVISIONAL PROCESSING COMPLETE
Wednesday, October 16, 2019DIVISIONAL REQUEST RECEIVED
Thursday, October 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 16, 2019TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 30, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 1 FILED
Tuesday, October 29, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 16, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 9, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, December 20, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 13, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 20, 2018UNDELIVERABLE MAIL - COURTESY COPY MAILED
Wednesday, September 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION E-MAILED
Wednesday, September 12, 2018NON-FINAL ACTION WRITTEN
Thursday, August 30, 2018ASSIGNED TO EXAMINER
Friday, May 18, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 12, 2018NEW APPLICATION ENTERED

Related Keywords

insight innovation breakthrough biosciences brii chronic infectious diseases treatment acute medicines biopharmaceutical drugs others pharmaceutical